Cargando…
Preferences and Health-Related Quality-of-Life Related to Disease and Treatment Features for Patients with Hemophilia A in a Canadian General Population Sample
BACKGROUND: Current treatments for hemophilia A in Canada include on-demand treatment as bleeds occur and regular intravenous prophylactic factor VIII (FVIII) infusions. The subcutaneous therapy emicizumab was recently approved for treatment of hemophilia A. The objective of this study was to estima...
Autores principales: | Johnston, Karissa, Stoffman, Jayson M, Mickle, Alexis T, Klaassen, Robert J, Diles, Demitri, Olatunde, Shade, Eliasson, Lina, Bahar, Roxana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238543/ https://www.ncbi.nlm.nih.gov/pubmed/34194224 http://dx.doi.org/10.2147/PPA.S316276 |
Ejemplares similares
-
Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
por: Wagg, Adrian, et al.
Publicado: (2016) -
Overcoming the barriers to implementation of competence-based medical education in post-graduate medical education: a narrative literature review
por: Stoffman, Jayson M.
Publicado: (2022) -
Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study
por: Dover, Saunya, et al.
Publicado: (2020) -
Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study
por: Stimec, Jennifer, et al.
Publicado: (2021) -
Transfusion related complications in hemophilia
por: Marwaha, Neelam
Publicado: (2013)